InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,573.60
(
-0.22%
)
Dow Jones
38,884.26
(
0.00%
)
Brent Oil
82.03
(
-1.01%
)
Bitcoin
62,415.88
(
0.13%
)
Post# of 3504
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Dennisb68

Send PM Follow Ignore
Followers 140
Posts 29804
Boards Moderated 0
Alias Born 02/03/2005

Dennisb68

Re: None

Wednesday, 04/04/2018 10:43:56 AM

Wednesday, April 04, 2018 10:43:56 AM

Post# of 3504
Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial

https://finance.yahoo.com/news/moleculin-announces-patients-treated-fda-123000005.html

Remember that when someone tries to convince you to buy or sell there is something in it for them. It's not because they are concerned about your investment.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MBRX News
More MBRX News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!